ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 84 filers reported holding ALBIREO PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $7,200 | -99.9% | 333,211 | +6.5% | 0.00% | 0.0% |
Q3 2022 | $6,054,000 | -7.3% | 312,744 | -4.9% | 0.00% | 0.0% |
Q2 2022 | $6,528,000 | -35.2% | 328,701 | -2.6% | 0.00% | 0.0% |
Q1 2022 | $10,067,000 | +44.9% | 337,493 | +13.1% | 0.00% | 0.0% |
Q4 2021 | $6,947,000 | -24.9% | 298,292 | +0.6% | 0.00% | 0.0% |
Q3 2021 | $9,251,000 | -9.2% | 296,520 | +2.4% | 0.00% | 0.0% |
Q2 2021 | $10,183,000 | +1.0% | 289,459 | +1.2% | 0.00% | -50.0% |
Q1 2021 | $10,080,000 | +4.2% | 285,978 | +10.9% | 0.00% | 0.0% |
Q4 2020 | $9,676,000 | +28.8% | 257,975 | +14.6% | 0.00% | +100.0% |
Q3 2020 | $7,514,000 | +49.3% | 225,181 | +18.5% | 0.00% | 0.0% |
Q2 2020 | $5,033,000 | +68.7% | 190,031 | +4.2% | 0.00% | 0.0% |
Q1 2020 | $2,984,000 | -58.7% | 182,286 | -35.9% | 0.00% | 0.0% |
Q4 2019 | $7,230,000 | +171.1% | 284,426 | +113.2% | 0.00% | 0.0% |
Q3 2019 | $2,667,000 | -34.7% | 133,398 | +5.3% | 0.00% | 0.0% |
Q2 2019 | $4,084,000 | +16.7% | 126,679 | +16.5% | 0.00% | 0.0% |
Q1 2019 | $3,501,000 | -26.8% | 108,716 | -44.2% | 0.00% | 0.0% |
Q4 2018 | $4,780,000 | +65.7% | 194,868 | +122.7% | 0.00% | 0.0% |
Q3 2018 | $2,884,000 | -0.1% | 87,512 | +7.6% | 0.00% | 0.0% |
Q2 2018 | $2,886,000 | +85.7% | 81,296 | +70.3% | 0.00% | 0.0% |
Q1 2018 | $1,554,000 | +90.7% | 47,736 | +49.9% | 0.00% | – |
Q4 2017 | $815,000 | +22.2% | 31,852 | 0.0% | 0.00% | – |
Q3 2017 | $667,000 | +22.2% | 31,852 | +20.0% | 0.00% | – |
Q2 2017 | $546,000 | +66.0% | 26,549 | +93.1% | 0.00% | – |
Q1 2017 | $329,000 | +41.2% | 13,746 | +4.5% | 0.00% | – |
Q4 2016 | $233,000 | – | 13,158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |